Inventor · disambiguated record
Frances M. Platt
Also filed as: PLATT FRANCES · PLATT FRANCES M · PLATT FRANCES MARY
22 granted patents·9 pending applications·909 citations·filing 1993–2016
97Inventor score
Files withMONSANTO CO11UNIV OXFORD INNOVATION LTD3BUTTERS TERENCE D2UNIV JEFFERSON2ACTELION PHARMACEUTICALS LTD1
Top patents by PatentIndex Score
31 records- 0197US5525616AMethod of inhibiting glycolipid synthesisMONSANTO CO·Filed 1995·Granted Jun 11, 1996·95 cites·7 claims
- 0296US5472969AMethod of inhibiting glycolipid synthesisMONSANTO CO·Filed 1994·Granted Dec 5, 1995·110 cites·4 claims
- 0395US6660749B2Inhibition of glycolipid biosynthesisUNIV OXFORD·Filed 2002·Granted Dec 9, 2003·55 cites·11 claims
- 0493US6465488B1Inhibition of glycolipid biosynthesisCHANCELLOR MASTERS & SCHOLARS·Filed 2000·Granted Oct 15, 2002·58 cites·3 claims
- 0591US5801185AMethod of treating Tay-Sachs diseaseMONSANTO CO·Filed 1997·Granted Sep 1, 1998·64 cites·4 claims
- 0690US5798366AMethod for treatment of CNS-involved lysosomal storage diseasesMONSANTO CO·Filed 1997·Granted Aug 25, 1998·106 cites·6 claims
- 0788US5399567AMethod of treating choleraMONSANTO CO·Filed 1993·Granted Mar 21, 1995·60 cites·5 claims
- 0886US6610703B1Method for treatment of glycolipid storage diseasesSEARLE & CO·Filed 1999·Granted Aug 26, 2003·71 cites·12 claims
- 0986US6291657B1Deoxygalactonojirimycin derivativesMONSANTO CO·Filed 1993·Granted Sep 18, 2001·43 cites·1 claims
- 1085US5580884ADeoxygalactonojirimycin derivativesMONSANTO CO·Filed 1995·Granted Dec 3, 1996·49 cites·6 claims
- 1183US9428541B2Substrate reduction therapyUS HEALTH·Filed 2013·Granted Aug 30, 2016·8 cites·3 claims
- 1282US9089515B2Long chain N-alkyl compounds and oxa-derivatives thereofZITZMANN NICOLE·Filed 2011·Granted Jul 28, 2015·9 cites·23 claims
- 1381US7816560B1Long chain n-alkyl compounds and oxa-derivatives thereofUNIV JEFFERSON·Filed 2000·Granted Oct 19, 2010·10 cites·4 claims
- 1480US8557844B2Substrate reduction therapyPLATT FRANCES MARY·Filed 2008·Granted Oct 15, 2013·10 cites·13 claims
- 1580US5786368ADeoxygalactonojirimycin derivativesMONSANTO CO·Filed 1996·Granted Jul 28, 1998·36 cites·8 claims
- 1679US5656641AMethod of inhibiting glycolipid synthesisMONSANTO CO·Filed 1995·Granted Aug 12, 1997·34 cites·5 claims
- 1775US7348000B2Therapeutic compositions and methods of treating glycolipid storage related disordersACTELION PHARMACEUTICALS LTD·Filed 2004·Granted Mar 25, 2008·12 cites·6 claims
- 1872US6465487B1Inhibition of membrane-associated viral replicationSYNERGY PHARMACEUTICALS INC·Filed 1998·Granted Oct 15, 2002·32 cites·38 claims
- 1972US5786369AMethod of inhibiting the surface expression of glycolipid receptors for bacteriaMONSANTO CO·Filed 1996·Granted Jul 28, 1998·23 cites·5 claims
- 2063US6069235AMethod for carbohydrate engineering of glycoproteinsMONSANTO CO·Filed 1994·Granted May 30, 2000·24 cites·3 claims
- 2158US9199935B2Pharmaceutically active piperidine derivativesBUTTERS TERENCE D·Filed 2014·Granted Dec 1, 2015·0 cites·2 claims
- 2255US2010137365A1Long chain N-alkyl compounds and oxa-derivatives thereofUNIV JEFFERSON·Filed 2010·Application pending·0 cites
- 2353US8729099B2Pharmaceutically active piperidine derivativesBUTTERS TERENCE D·Filed 2005·Granted May 20, 2014·0 cites·3 claims
- 2451US2004097551A1Pharmaceutically active piperidine derivativesFiled 2003·Application pending·0 cites
- 2550US2004019082A1Reversible infertility in male mice following oral administration of alkylated imino sugars: a non-hormonal approach to male contraceptionUNITED THERAPEUTICS CORP·Filed 2003·Application pending·0 cites
- 2647US2006025449A1Use of N-substituted imino sugars for appetite suppressionUNITED THERAPEUTICS·Filed 2005·Application pending·0 cites
- 2742US2017190772A1Treatment of lysosomal disorders (il-1 antagonists)UNIV OXFORD INNOVATION LTD·Filed 2015·Application pending·0 cites
- 2842US2003069200A1Use of glucosylceramide synthesis inhibitors in brain cancertherapyFiled 2002·Application pending·0 cites
- 2941US2010022620A1Epitope reduction therapyCRISPIN MATTHEW DAVID MAX·Filed 2007·Application pending·0 cites
- 3039US2018125796A1Treatment of mycobacterial infectionUNIV OXFORD INNOVATION LTD·Filed 2016·Application pending·0 cites
- 3139US2017165361A1Treatment of lysosomal disorders (anti-tnf therapy)UNIV OXFORD INNOVATION LTD·Filed 2015·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →